Tumor ablation induced anti-tumor immunity: destruction of the tumor in situ with the aim to evoke a robust anti-tumor immune response

Coley, W. B. (1893). The treatment of malignant tumors by repeated inoculations of erysipelas: With a report of ten original cases. American Journal of the Medical Sciences, 10, 487–511.

Article  Google Scholar 

Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021). Therapeutic cancer vaccines. Nature Reviews Cancer, 21(6), 360–378. https://doi.org/10.1038/s41568-021-00346-0

Article  CAS  PubMed  Google Scholar 

Prehn, R. T., & Main, J. M. (1957). Immunity to methylcholanthrene-induced sarcomas. Journal of the National Cancer Institute, 18(6), 769–778.

CAS  PubMed  Google Scholar 

Kaczmarek, M., Poznańska, J., Fechner, F., Michalska, N., Paszkowska, S., Napierała, A., & Mackiewicz, A. (2023). Cancer vaccine therapeutics: Limitations and effectiveness—A literature review. Cells, 12(17), 2159. https://doi.org/10.3390/cells12172159

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mole, R. H. (1953). Whole body irradiation; radiobiology or medicine? British Journal of Radiology, 26(305), 234–241. https://doi.org/10.1259/0007-1285-26-305-234

Article  CAS  PubMed  Google Scholar 

Nobler, M. P. (1969). The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology, 93, 410–412.

Article  CAS  PubMed  Google Scholar 

Deneufbourg, J. M. (1975). Radiocurability of a transplantable murine sarcoma as influenced by immune competence of the host and adjuvant active specific immunotherapy. Strahlentherapie, 149(4), 457–462.

CAS  PubMed  Google Scholar 

Tsuchiya, T. (1976). The role of immune response following local irradiation. I. Anti-tumor cell-mediated immunity (author’s transl). Nihon Igaku Hoshasen Gakkai Zasshi, 36(10), 922–9. Japanese.

CAS  PubMed  Google Scholar 

Keisari, Y., Popovtzer, A., & Kelson, I. (2020). Effective treatment of metastatic cancer by an innovative intratumoral alpha particle-mediated radiotherapy in combination with immunotherapy: A short review. Journal of Physics: Conference Series, 1662, 012016. https://doi.org/10.1088/1742-6596/1662/1/012016

Article  CAS  Google Scholar 

Vroomen, L. G. P. H., Petre, E. N., Cornelis, F. H., Solomon, S. B., & Srimathveeravalli, G. (2017). Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences? Diagnostic and Interventional Imaging, 98(9), 609–617. https://doi.org/10.1016/j.diii.2017.07.007

Article  CAS  PubMed  Google Scholar 

Keisari, Y. (2017). Tumor abolition and antitumor immunostimulation by physico-chemical tumor ablation. Frontiers Biosc (Landmark Edition), 22, 310–347.

Article  CAS  Google Scholar 

Keisari, Y. (2013). Tumor ablation: Effects on systemic and local anti-tumor immunity and on other tumor-microenvironment interactions. Springer. https://www.springer.com/gp/book/9789400746930.

Demaria, S., Guha, C., Schoenfeld, J., Morris, Z., Monjazeb, A., Sikora, A., Crittenden, M., Shiao, S., Khleif, S., Gupta, S., Formenti, S. C., Vikram, B., Coleman, C. N., & Ahmed, M. M. (2021). Radiation dose and fraction in immunotherapy: One-size regimen does not fit all settings, so how does one choose? Journal for Immunotherapy of Cancer, 9(4), e002038. https://doi.org/10.1136/jitc-2020-002038

Article  PubMed  PubMed Central  Google Scholar 

Keisari, Y., & Kelson, I. (2021). The potentiation of anti-tumor immunity by tumor abolition with alpha particles, protons or carbon ion radiation and its enforcement by combination with immunoadjuvants or inhibitors of immune suppressor cells and check point molecules. Cells, 10, 228. https://doi.org/10.3390/cells10020228

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020). Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews. Clinical Oncology, 17(12), 725–741. https://doi.org/10.1038/s41571-020-0413-z

Article  PubMed  Google Scholar 

Erinjeri, J. P., Fine, G. C., Adema, G. J., Ahmed, M., Chapiro, J., den Brok, M., Duran, R., Hunt, S. J., Johnson, D. T., Ricke, J., Sze, D. Y., Toskich, B. B., Wood, B. J., Woodrum, D., & Goldberg, S. N. (2019). Immunotherapy and the interventional oncologist: Challenges and opportunities-A society of interventional oncology white paper. Radiology, 292(1), 25–34. https://doi.org/10.1148/radiol.2019182326

Article  PubMed  Google Scholar 

Kornepati, A. V. R., Rogers, C. M., Sung, P., & Curiel, T. J. (2023). The complementarity of DDR, nucleic acids and anti-tumour immunity. Nature, 619(7970), 475–486. https://doi.org/10.1038/s41586-023-06069-6

Article  CAS  PubMed  Google Scholar 

Ye, Z., Shi, Y., Lees-Miller, S. P., & Tainer, J. A. (2021). Function and molecular mechanism of the DNA damage response in immunity and cancer immunotherapy. Frontiers in Immunology, 12, 797880. https://doi.org/10.3389/fimmu.2021.797880

Article  CAS  PubMed  PubMed Central  Google Scholar 

van den Bijgaart, R. J. E., Schuurmans, F., Fütterer, J. J., Verheij, M., Cornelissen, L. A. M., & Adema, G. J. (2021). Immune modulation plus tumor ablation: Adjuvants and antibodies to prime and boost anti-tumor immunity in situ. Frontiers in Immunology, 12, 617365. https://doi.org/10.3389/fimmu.2021.617365

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baude, J., Limagne, E., Ladjohounlou, R., & Mirjolet, C. (2023). Combining radiotherapy and NK cell-based therapies: The time has come. International Review of Cell and Molecular Biology, 378, 31–60. https://doi.org/10.1016/bs.ircmb.2023.02.003

Article  PubMed  Google Scholar 

Lamichhane, P., Amin, N. P., Agarwal, M., & Lamichhane, N. (2018). Checkpoint inhibition: Will combination with radiotherapy and nanoparticle-mediated delivery improve efficacy? Medicines (Basel), 5(4), 114. https://doi.org/10.3390/medicines5040114

Article  CAS  PubMed  Google Scholar 

Shannon, A. H., Manne, A., Diaz Pardo, D. A., & Pawlik, T. M. (2023). Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma. Frontiers in Oncology, 13, 1193762. https://doi.org/10.3389/fonc.2023.1193762

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, X., Gao, M., Xu, R., Tao, Y., Luo, W., Wang, B., Zhong, W., He, L., & He, Y. (2022). Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors. Frontiers in Immunology, 13, 969447. https://doi.org/10.3389/fimmu.2022.969447

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eresen, A., Yang, J., Scotti, A., Cai, K., Yaghmai, V., & Zhang, Z. (2021). Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma. Ann Transl Med, 9(13), 1089. https://doi.org/10.21037/atm-21-539

Article  CAS  PubMed  PubMed Central  Google Scholar 

Persa, E., Balogh, A., Sáfrány, G., & Lumniczky, K. (2015). The effect of ionizing radiation on regulatory T cells in health and disease. Cancer Letters, 368(2), 252–261. https://doi.org/10.1016/j.canlet.2015.03.003

Article  CAS  PubMed  Google Scholar 

Markezana, A., Goldberg, S. N., Kumar, G., Zorde-Khvalevsky, E., Gourevtich, S., Rozenblum, N., Galun, E., & Ahmed, M. (2021). Incomplete thermal ablation of tumors promotes increased tumorigenesis. International Journal of Hyperthermia, 38(1), 263–272. https://doi.org/10.1080/02656736.2021.1887942

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif